Supreme Court Won't Take On Omnicef Patent Case
In a setback for drug companies trying to enforce broad interpretations of their patents, the U.S. Supreme Court on Monday declined to hear Astellas Pharma Inc.'s case against generic-drug makers that...To view the full article, register now.
Already a subscriber? Click here to view full article